info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
Home » Healthcare

Healthcare

Anti-Obesity Drugs Market By Drug Type (Peripherally Acting Drugs; Centrally Acting Drugs; Combination Drugs); By Prescription Type (Prescription Drugs; Over-the-Counter (OTC) Drugs); By Distribution Channel (Hospital Pharmacies; Online Pharmacies; Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Anti-obesity Drugs Market Size & Overview

The Anti-Obesity Drugs Market was valued at USD 6.6 billion in 2024 & is projected to reach USD 25 billion by 2030, expanding at a CAGR of 20% during the forecast period. This growth is fueled by the rising global obes... Read More

Published Date: APR-2025 | No Of Pages:150 | $ 4485

Blood Pressure Monitoring Devices Market By Product Type (Digital Blood Pressure Monitors; Aneroid Blood Pressure Monitors; Ambulatory Blood Pressure Monitors (ABPM); Wrist Blood Pressure Monitors; Others); By End-User (Hospitals & Clinics; Ambulatory Surgical Centers; Home Healthcare Settings; Diagnostic Centers; Others); By Distribution Channel (Retail Pharmacies; Online Platforms; Hospital Pharmacies; Direct Sales); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Blood Pressure Monitoring Devices Market Size & Overview

The global blood pressure monitoring devices market was valued at $2.4 billion in 2024 and is projected to reach $4.1 billion by 2030, growing at a CAGR of 9.2% during the forecast period. Blood pressure mon... Read More

Published Date: APR-2025 | No Of Pages:150 | $ 4485

Mammography Market By Product Type (Film-Screen Systems; Digital Systems; 3D Systems; Analog Systems; Others); By Technology (CAD Mammography; Breast Tomosynthesis; Digital Mammography); By Modality (Portable; Non-Portable); By End User (Hospitals; Diagnostic Imaging Centers; Specialty Clinics; Ambulatory Surgical Centers; Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Mammography Market Size & Overview

The Global Mammography Market is estimated to be valued at USD 2.8 billion and is projected to surpass USD 4.3 billion by 2030, growing at a CAGR of 10.1% during the forecast period. The growth is driven by the rising global burd... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

T-cell Therapy Market By Type (CAR T-cell Therapy; Tumor Infiltrating Lymphocytes (TIL)-based; T Cell Receptor (TCR)-based); By Indication (Hematologic Malignancies (Leukemia; Lymphoma; Myeloma); Solid Tumors (Melanoma; Brain & Central Nervous System; Liver Cancer; Others); Others); By End-User (Hospitals; Cancer Treatment Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

T-cell Therapy Market Size & Overview

The Global T-cell Therapy Market was valued at approximately USD 3.7 billion in 2024 and is projected to reach USD 9.3 billion by 2030, growing at a robust CAGR of 15.6% during the forecast period. T-cell therapies including C... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Vitrectomy Devices Market By Product Type (Vitrectomy Machines; Vitrectomy Probes; Vitrectomy Packs; Illumination Systems; Surgical Instruments & Accessories); By Surgery Type (Posterior Vitrectomy; Anterior Vitrectomy; Combined Procedures); By Application (Retinal Detachment; Diabetic Retinopathy; Macular Hole; Vitreous Hemorrhage; Others (e.g., Trauma, Infection, ROP)); By End User (Hospitals; Ophthalmic Clinics; Ambulatory Surgical Centers (ASCs); Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Vitrectomy Devices Market Size & Overview

The Global Vitrectomy Devices Market is estimated to be valued at USD 1.6 billion and is projected to surpass USD 2.2 billion by 2030, growing at a CAGR of 5.5% during the forecast period. The growth is fueled by the advan... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Bispecific Antibodies Market By Type (IgG-like Bispecific Antibodies; Non-IgG-like Bispecific Antibodies; Bispecific T-cell Engagers (BiTEs); Dual-Variable Domain Antibodies (DVD-Ig)); By Application (Oncology; Autoimmune Diseases; Infectious Diseases; Other Applications); By Mechanism of Action (Immune Modulation; Direct Tumor Targeting; T-cell Engagement); By End-User (Pharmaceutical and Biotechnology Companies; Hospitals and Clinics; Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Bispecific Antibodies Market Size & Overview

The bispecific antibodies market was valued at approximately $6.5 billion in 2024 and is projected to reach $15.1 billion by 2030, growing at a CAGR of 14.9%. The market is driven by the increasing prevalence of cancer,... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Embolotherapy Market By Product Type (Liquid Embolics (Glues, Polymer Agents), Microspheres (Drug-Eluting, Calibrated, Radiopaque), Vascular Plugs (Mechanical Occlusion Devices), Embolization Coils (Pushable & Detachable), Guidewires, Microcatheters); By Application (Oncology, Neurology, Peripheral Vascular Diseases, Urology, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Embolotherapy Market Size & Overview

The embolotherapy market was valued at approximately $3.9 billion in 2024 and is projected to reach $6.2 billion by 2030, growing at a CAGR of 7.9%. The growth of the embolotherapy market is driven by advancements in embolic te... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Retinal Imaging Devices Market By Product Type (Fundus Cameras; Optical Coherence Tomography (OCT); Retinal Ultrasound Imaging Systems; Fluorescein Angiography Devices; Hyperspectral Retinal Imaging Devices); By Technology (Conventional Imaging; Digital Imaging; Autofluorescence; Fluorescein Angiography); By End User (Hospitals; Ophthalmic Clinics; Ambulatory Surgical Centers (ASCs); Diagnostic Imaging Centers; Academic & Research Institutes); By Disease Indication (Diabetic Retinopathy; Age-related Macular Degeneration (AMD); Glaucoma; Retinal Vein Occlusion; Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Retinal Imaging Devices Market Size & Overview

The retinal imaging devices market was valued at USD 2.85 billion in 2023 and is projected to reach USD 4.93 billion by 2030, expanding at a CAGR of 8.2% during the forecast period (2024–2030). Retinal imaging t... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Pharmacogenomics Market By Technology (Polymerase Chain Reaction (PCR); Microarray; Sequencing (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis; Others); By Application (Oncology; Cardiovascular Diseases; Neurological Diseases; Infectious Diseases; Psychiatric Disorders; Pain Management; Others); By Product & Service (Reagents & Kits; Instruments; Software & Bioinformatics Tools; Services (Genotyping, SNP Analysis, Drug-Gene Interaction Testing, Others)); By End User (Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Academic & Research Institutions; Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Pharmacogenomics Market Size & Overview

The Pharmacogenomics Market was valued at $9.8 billion in 2024 and is projected to reach $22.5 billion by 2030, growing at a CAGR of 14.7% during the forecast period. This growth is driven by the increasing demand for person... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Biomarkers Market By Type (Genomic Biomarkers; Proteomic Biomarkers; Metabolomic Biomarkers; Imaging Biomarkers; Others (Transcriptomic, Lipidomic Biomarkers, etc.)); By Application (Disease Diagnosis & Risk Assessment; Drug Discovery & Development; Personalized Medicine; Companion Diagnostics; Others (Toxicology Studies, Prognostic Biomarkers, etc.)); By Disease Area (Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases; Metabolic Disorders; Others (Inflammatory Diseases, Organ-Specific Biomarkers, etc.)); By End User (Pharmaceutical & Biotechnology Companies; Hospitals & Diagnostic Laboratories; Research & Academic Institutes; Contract Research Organizations (CROs); Others (Regulatory Agencies, Government Institutions, etc.)); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Biomarkers Market Size & Overview

The Biomarkers Market was valued at $68.3 billion in 2024 and is projected to reach $142.5 billion by 2030, growing at a CAGR of 12.6%. This market growth is fueled by the growing demand for personalized medicine, the rise in chro... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485